These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35751775)

  • 1. Increased levels of insulin-degrading enzyme in patients with type 2 diabetes mellitus.
    Kullenberg H; Rossen J; Johansson UB; Hagströmer M; Nyström T; Kumlin M; Svedberg MM
    Endocrine; 2022 Sep; 77(3):561-565. PubMed ID: 35751775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer's disease, and healthy controls: a comparative study.
    Kullenberg H; Rossen J; Johansson UB; Hagströmer M; Nyström T; Kumlin M; Svedberg MM
    Endocrine; 2024 May; 84(2):450-458. PubMed ID: 37980298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of insulin degrading enzyme activity and liver cell proliferation.
    Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
    Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?
    Pivovarova O; Höhn A; Grune T; Pfeiffer AF; Rudovich N
    Ann Med; 2016 Dec; 48(8):614-624. PubMed ID: 27320287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Sun J; Xia W; Cai R; Wang P; Huang R; Sun H; Tian S; Dong X; Wang S
    Curr Alzheimer Res; 2016; 13(12):1337-1345. PubMed ID: 27306699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.
    Rudovich N; Pivovarova O; Fisher E; Fischer-Rosinsky A; Spranger J; Möhlig M; Schulze MB; Boeing H; Pfeiffer AF
    J Mol Med (Berl); 2009 Nov; 87(11):1145-51. PubMed ID: 19809796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs.
    Martín-Martín Y; Pérez-García A; Torrecilla-Parra M; Fernández-de Frutos M; Pardo-Marqués V; Casarejos MJ; Busto R; Ramírez CM
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Insulin-Degrading Enzyme in Insulin Clearance.
    Leissring MA; González-Casimiro CM; Merino B; Suire CN; Perdomo G
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphism rs2421943 of the insulin-degrading enzyme and schizophrenia: Preliminary report.
    Ambrozová L; Zeman T; Janout V; Janoutová J; Lochman J; Šerý O
    J Clin Lab Anal; 2023 Jul; 37(13-14):e24949. PubMed ID: 37515308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
    Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus.
    Haque R; Nazir A
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):259-64. PubMed ID: 24059320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?
    Liu Z; Zhu H; Fang GG; Walsh K; Mwamburi M; Wolozin B; Abdul-Hay SO; Ikezu T; Leissring MA; Qiu WQ
    J Alzheimers Dis; 2012; 29(2):329-40. PubMed ID: 22232014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review.
    Azam MS; Wahiduzzaman M; Reyad-Ul-Ferdous M; Islam MN; Roy M
    Pharm Res; 2022 Apr; 39(4):611-629. PubMed ID: 35378698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.
    Bartl J; Scholz CJ; Hinterberger M; Jungwirth S; Wichart I; Rainer MK; Kneitz S; Danielczyk W; Tragl KH; Fischer P; Riederer P; Grünblatt E
    BMC Med Genet; 2011 Nov; 12():151. PubMed ID: 22107728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-degrading enzyme higher in subjects with metabolic syndrome.
    Sofer Y; Nash Y; Osher E; Fursht O; Goldsmith G; Nahary L; Shaklai S; Tordjman KM; Serebro M; Touati EB; Yacobi Bach M; Marcus Y; Tal B; Sack J; Shefer G; Margaliot M; Landis N; Goldiner I; Abu Ahmad W; Stern N; Benhar I; Frenkel D
    Endocrine; 2021 Feb; 71(2):357-364. PubMed ID: 33398768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FADD Phosphorylation Modulates Blood Glucose Levels by Decreasing the Expression of Insulin-Degrading Enzyme.
    Lin Y; Liu J; Chen J; Yao C; Yang Y; Wang J; Zhuang H; Hua ZC
    Mol Cells; 2020 Apr; 43(4):373-383. PubMed ID: 32191993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 increases the expression and activity of insulin-degrading enzyme.
    Kurauti MA; Costa-Júnior JM; Ferreira SM; Santos GJ; Sponton CHG; Carneiro EM; Telles GD; Chacon-Mikahil MPT; Cavaglieri CR; Rezende LF; Boschero AC
    Sci Rep; 2017 Apr; 7():46750. PubMed ID: 28429777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
    Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
    Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.